Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Franciszek
Franciszek Baszczok, Katowice PL
| Patent application number | Description | Published |
|---|---|---|
| 20110097444 | MICROBIOLOGICAL REPROCESSING OF DEGUMMING RESIDUE FORMED DURING BIODIESEL PRODUCTION - An industrial method of reprocessing degumming residue from the initial purification of natural fats as well as a feed additive, which may be produced using the said method. | 04-28-2011 |
| 20110111090 | MICROBIOLOGICAL REPROCESSING OF BY-PRODUCTS OF BIODIESEL PRODUCTION - An industrial method of reprocessing a mixture of by-products produced during biodiesel production containing a glycerol fraction and degumming residue as well as a feed additive, which may be obtained by this method. | 05-12-2011 |
Franciszek Hennel, Karlsruhe DE
| Patent application number | Description | Published |
|---|---|---|
| 20100237861 | Method for mapping of the radio frequency field amplitude in a magnetic resonance imaging system using adiabatic excitation pulses - A method for determining the spatial distribution of the magnitude of the radio frequency transmission field B1 in a magnetic resonance imaging apparatus, wherein the method comprises performing an MRI experiment in which a B1-sensitive complex image (SI) of a sample is obtained, wherein the phase distribution within the B1-sensitive complex image (SI) depends on the spatial distribution of the magnitude of the field B1. For establishing the dependency of the phase distribution within the B1-sensitive complex image (SI) on the spatial distribution of the field B1, one or more adiabatic RF pulses are applied. The method provides a simple procedure for mapping the B1 field of a magnetic resonance imaging apparatus with an improved accuracy and a wider measurement range. | 09-23-2010 |
| 20100244827 | Simultaneous excitation and acquisition in magnetic resonance - A method for magnetic resonance spectroscopy (=MRS) or magnetic resonance imaging (=MRI) in which an NMR time-domain signal is created by an RF excitation pulse applied to an object in the presence of an applied magnetic field that may depend on spatial position and/or time, the time-domain signal being generated by an excited transverse nuclear magnetisation precessing about the applied magnetic field, whereby the RF excitation pulse is adapted to cover a whole range of NMR frequencies of interest present in the object, and time-domain signal acquisition takes place during, or during and after the application of the RF excitation pulse, is characterized in that spectral or image data are reconstructed by a matrix product of a reconstruction matrix and a vector of time-domain signal points, the reconstruction matrix being an inversion of an encoding matrix A | 09-30-2010 |
| 20110234227 | Designing a time dependency for a k-space trajectory, in particular a spiral - A method for designing the time dependence function k | 09-29-2011 |
Franciszek Kasprzykowski, Pruszcz Gdanski PL
| Patent application number | Description | Published |
|---|---|---|
| 20080255055 | Use of Derivatives of Dipeptides for the Manufacture of of a Medicament for the Treamtent of Microbial Infections - The invention relates to compositions comprising a compound based on the general formula (I) R | 10-16-2008 |
| 20090118198 | NOVEL PEPTIDE DERIVATIVES USEFUL AS ANTIMICROBIAL AGENTS FOR TREATING WOUNDS - The invention relates to a compound having the general formula (I) R | 05-07-2009 |
| 20100247648 | ANTIMICROBIAL COMPOUNDS - The invention relates to compositions comprising a compound based on the general formula (I) | 09-30-2010 |
Franciszek Kasprzykowski, Gdandski PL
| Patent application number | Description | Published |
|---|---|---|
| 20120108515 | NOVEL PEPTIDE DERIVATIVES FOR TREATMENT, PREVENTION OR ALLEVIATION OF A CONDITION ASSOCIATED WITH BONE LOSS OR LOW BONE DENSITY OR TO INHIBIT OSTEOCLAST DIFFERENTIATION AND STIMULATION - Novel compounds which may be for treatment, prevention or alleviation of a condition associated with bone loss or low bone density or to inhibit osteoclast differentiation and stimulation, bone resorption, or loosening of a prosthetic device. | 05-03-2012 |